Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Boston Partners

Boston Partners decreased its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 3.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 203,697 shares of the health services provider's stock after selling 8,004 shares during the quarter. Boston Partners owned 0.62% of Amedisys worth $19,355,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Cetera Trust Company N.A bought a new stake in Amedisys during the fourth quarter worth about $215,000. CWM LLC raised its stake in shares of Amedisys by 40.4% in the fourth quarter. CWM LLC now owns 2,629 shares of the health services provider's stock worth $250,000 after acquiring an additional 757 shares during the last quarter. Contravisory Investment Management Inc. acquired a new position in Amedisys during the 4th quarter worth $258,000. Mesirow Institutional Investment Management Inc. increased its stake in shares of Amedisys by 9.9% in the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider's stock valued at $270,000 after buying an additional 257 shares during the period. Finally, Argonautica Private Wealth Management Inc. lifted its stake in shares of Amedisys by 6.1% during the third quarter. Argonautica Private Wealth Management Inc. now owns 3,003 shares of the health services provider's stock valued at $280,000 after acquiring an additional 172 shares during the period. Institutional investors and hedge funds own 94.36% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on AMED shares. Raymond James reaffirmed a "market perform" rating on shares of Amedisys in a research note on Tuesday, March 26th. Royal Bank of Canada upped their target price on shares of Amedisys from $97.00 to $100.00 and gave the company an "outperform" rating in a research report on Monday, March 25th. Cantor Fitzgerald restated a "neutral" rating and issued a $101.00 price target on shares of Amedisys in a research report on Thursday, April 25th. Finally, StockNews.com raised Amedisys from a "hold" rating to a "buy" rating in a research note on Saturday, May 4th. Seven research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Amedisys currently has an average rating of "Hold" and a consensus target price of $100.80.

Amedisys Stock Down 0.6 %

AMED stock traded down $0.54 during mid-day trading on Thursday, hitting $94.95. 191,959 shares of the company were exchanged, compared to its average volume of 273,823. The firm's 50 day simple moving average is $92.54 and its 200 day simple moving average is $93.46. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.09. Amedisys, Inc. has a 1-year low of $74.61 and a 1-year high of $96.44. The firm has a market cap of $3.10 billion, a P/E ratio of -149.20, a P/E/G ratio of 3.55 and a beta of 0.84.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, beating analysts' consensus estimates of $1.02 by $0.01. The firm had revenue of $571.41 million during the quarter, compared to the consensus estimate of $565.38 million. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The business's revenue was up 2.7% compared to the same quarter last year. During the same period last year, the company earned $1.00 earnings per share. On average, sell-side analysts predict that Amedisys, Inc. will post 4.57 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.